Yuanwei Zang
-
- Cancer, Hypoxia, and Metabolism 2
- Biochemistry top 10%
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- Renal and related cancers 2
-
- Cancer Mechanisms and Therapy 2
-
- Renal cell carcinoma treatment 2
-
- Cancer Research and Treatments 2
-
- Endoplasmic Reticulum Stress and Disease 2
- Co-authors
- Zhonghua XuLiang FangJuchao RenYongzhen ZhangYong‐Zhen ZhangLiang QiaoWenjun NiJingxin Li
- Journals
- Journal of Clinical Oncology (1 paper)The Journal of Cell Biology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yuanwei Zang
19 papers receiving 370 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 115
- Biochemistry 43
- Molecular Biology 197
- Endocrine and Autonomic Systems 19
- Pathology and Forensic Medicine 49
Countries citing papers authored by Yuanwei Zang
This map shows the geographic impact of Yuanwei Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanwei Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanwei Zang more than expected).
Fields of papers citing papers by Yuanwei Zang
This network shows the impact of papers produced by Yuanwei Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanwei Zang. The network helps show where Yuanwei Zang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanwei Zang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 38 | |
| 7 | 2019 | 25 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 45 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 22 | |
| 12 | 2018 | 9 | |
| 13 | 2017 | 30 | |
| 14 | Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo. | 2017 | 43 |
| 15 | 2017 | 6 | |
| 16 | 2017 | 1 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 14 | |
| 19 | 2012 | 30 | |
| 20 | 2010 | 20 |
About Yuanwei Zang
Yuanwei Zang is a scholar working on Cancer Research, Energy Engineering and Power Technology and Biochemistry, having authored 21 papers that have together received 375 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Cancer Research (115 citations), Biochemistry (43 citations) and Molecular Biology (197 citations). Yuanwei Zang has collaborated with scholars based in China and United States. Frequent co-authors include Zhonghua Xu, Liang Fang, Juchao Ren, Yongzhen Zhang, Yong‐Zhen Zhang, Liang Qiao, Wenjun Ni, Jingxin Li, Zeyan Li and Yongxiang Li. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.